Sector
PharmaceuticalsOpen
₹3.82Prev. Close
₹4.32Turnover(Lac.)
₹2.21Day's High
₹4.45Day's Low
₹3.8252 Week's High
₹6.8752 Week's Low
₹4.01Book Value
₹1.41Face Value
₹1Mkt Cap (₹ Cr.)
23.32P/E
0EPS
0Divi. Yield
01 Aug 2024
12:00 AM
AGM
Announcement Date: 01 Aug, 2024
30 Jan 2025
12:00 AM
Board Meeting
Agenda : Audited Result
1 Aug 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.37 | 5.37 | 5.37 | 5.37 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.96 | 1.86 | 1.78 | 1.47 |
Net Worth | 7.33 | 7.23 | 7.15 | 6.84 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 13.73 | 11.97 | 9.51 | 4.79 |
yoy growth (%) | 14.69 | 25.93 | 98.53 | 38.27 |
Raw materials | -8.2 | -7.36 | -5.43 | -2.81 |
As % of sales | 59.72 | 61.44 | 57.13 | 58.71 |
Employee costs | -1.32 | -1.21 | -0.97 | -0.9 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.55 | 0.58 | 0.39 | -0.17 |
Depreciation | -0.25 | -0.25 | -0.27 | -0.3 |
Tax paid | -0.11 | -0.01 | -0.12 | 0.01 |
Working capital | 0.44 | 0.79 | 0.6 | -0.09 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 14.69 | 25.93 | 98.53 | 38.27 |
Op profit growth | -34.7 | -1.7 | 807.39 | -126 |
EBIT growth | -4.22 | 45.32 | -345.15 | -64.66 |
Net profit growth | -22.22 | 106.71 | -279.86 | -51.01 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Mahendra C Raycha
Non Executive Director
Neela Raycha
Non Executive Director
Atul Thakkar.
Joint Managing Director
Akshit Raycha
Company Sec. & Compli. Officer
Mihir Satishkumar Shah
Independent Director
Parag Dave
Independent Director
Rutvik Sanjaykumar Thakkar
Independent Director
Rajesh Sutaria
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Zenith Health Care Ltd
Summary
Zenith Healthcare Limited, incorporated in 1994, is an ISO 9001:2008 & WHO-cGMP certified company, which is strategically located in Changodar, from Ahmedabad International Airport and 20 Km from the main city of Ahmedabad in Gujarat which is the hub of Indian Pharmaceutical Industry. The Company is engaged into manufacturing of tablets, capsules, ointments, and liquid injectable among others.The Company is a fully integrated, global healthcare provider, with a core competence in the field of healthcare. It provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients,animal healthcare products and to various wellness products. It has its manufacturing facilities located at Changodar, Gujarat with installed capacity to manufacture 168 million tablets, 37.5 million capsules and 90 million liquids. Zenith is a technology driven company setting up high benchmarks for excellence in Product Quality and adherence to stringent delivery Schedule. Through this flexible approach, the Company is able to integrate perfectly into their supply chain for solid dosage forms in General and Beta-Lactam Tablets, Capsules, Oral Liquids and Dry Powder Oral Suspension. It also has isolated and dedicated production facilities for General and Beta-Lactam. It process quality products through reliable supply.
Read More
What is the Zenith Health Care Ltd share price today?
The Zenith Health Care Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹4.34 today.
What is the Market Cap of Zenith Health Care Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenith Health Care Ltd is ₹23.32 Cr. as of 09 May ‘25
What is the PE and PB ratio of Zenith Health Care Ltd?
The PE and PB ratios of Zenith Health Care Ltd is 0 and 3.06 as of 09 May ‘25
What is the 52 Week High and Low of Zenith Health Care Ltd?
The 52-week high/low is the highest and lowest price at which a Zenith Health Care Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Zenith Health Care Ltd is ₹4.01 and ₹6.87 as of 09 May ‘25
What is the CAGR of Zenith Health Care Ltd?
Zenith Health Care Ltd's CAGR for 5 Years at 31.71%, 3 Years at -12.64%, 1 Year at -6.29%, 6 Month at -28.00%, 3 Month at -15.46% and 1 Month at -6.49%.
What is the shareholding pattern of Zenith Health Care Ltd?
The shareholding pattern of Zenith Health Care Ltd is as follows:
Promoters - 28.74 %
Institutions - 0.39 %
Public - 70.87 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
